Edition:
United Kingdom

Arbutus Biopharma Corp (ABUS.OQ)

ABUS.OQ on NASDAQ Stock Exchange Global Select Market

2.33USD
21 May 2019
Change (% chg)

$-0.03 (-1.27%)
Prev Close
$2.36
Open
$2.37
Day's High
$2.46
Day's Low
$2.31
Volume
51,195
Avg. Vol
60,544
52-wk High
$12.50
52-wk Low
$2.18

About

Arbutus Biopharma Corp is a Canada-based biopharmaceutical company. The Company is dedicated to discovering, developing and commercializing a cure for patients suffering from chronic hepatitis B infection, a disease of the liver caused by hepatitis B virus (HBV). The Company develops a portfolio of drug candidates with multiple... (more)
No analyst recommendations are available for .

Overall

Beta: 0.72
Market Cap(Mil.): $493.14
Shares Outstanding(Mil.): 55.03
Dividend: --
Yield (%): --

Financials

  ABUS.OQ Industry Sector
P/E (TTM): -- 29.30 32.55
EPS (TTM): -2.15 -- --
ROI: -51.57 14.23 13.82
ROE: -55.72 15.46 15.24

Earnings vs. Estimates